Accelerated Patent Invalidity Searches

Meeting Tight Court-Ordered Deadlines Introduction Patent litigation runs on schedules. Courts and specialized forums such as the U.S. International Trade Commission (ITC), set deadlines that leave defendants only weeks to identify prior art, analyze claims and commit to invalidity positions. When a defendant is served with a complaint, the clock starts for responsive pleadings, invalidity […]

Utility Model Invalidity: Cross-Border Prior Art Strategies Beyond US Patent Filings

How to find, prove and present prior art from outside the United States when challenging utility models Introduction The United States has no utility model system, so many US-trained practitioners are unfamiliar with how these rights are granted, enforced and attacked. Yet utility models (also called petty patents, short-term patents or innovation protections in some […]

Navigation and GPS Patent Invalidity: Military NAVSTAR Documents and Academic Prior Art

Locating, authenticating and using early GPS literature to challenge patent claims 1. Introduction The Global Positioning System (GPS) began as a U.S. military program called NAVSTAR (Navigation System with Timing and Ranging) and was developed across the 1970s and 1980s, declared operational in the mid-1990s and opened to civilian use long before that. Because so […]

mRNA Sequence Listing Requirements for Vaccine and Therapeutic Patents

Applying WIPO Standard ST.26 to modified, structured and multi-component RNA inventions 1. Introduction The success of mRNA vaccines and the growth of RNA therapeutics (protein-replacement mRNA, self-amplifying RNA, circular RNA, mRNA-encoded antibodies, in vivo gene editing payloads and cancer neoantigen vaccines) have made RNA sequences central to patent filings. In these filings, the sequence listing […]

Hearing Aid Technology Patent Invalidity: FDA and Acoustical Society of America Prior Art

Using regulatory records and acoustics-standards literature to challenge hearing aid patents under §§ 102 and 103 1. Introduction Hearing aids are a mature, heavily regulated and richly documented technology. Features that appear novel in a patent claim, such as directional microphones, feedback cancellation, multiband compression, noise reduction, wireless streaming, or self-fitting, often have a long […]

Medical Imaging Patent Invalidity: Searching SPIE and Radiology Society Prior Art

Where invalidating references hide in conference proceedings, society journals and scientific meetings and how to prove they were publicly accessible. Introduction Medical imaging is a field in which technical progress is often published before it is patented. New reconstruction algorithms, contrast techniques, computer-aided detection methods and AI-based diagnostic tools frequently debut at scientific conferences, in […]

Microbiome Patent Invalidity

NIH Human Microbiome Project Data as Anticipatory Prior Art Introduction Microbiome therapeutics, diagnostics and probiotics have attracted substantial investment and with it a growing number of patents. Typical claims cover compositions comprising specific bacterial strains or consortia, methods of treating disease by administering them, diagnostic methods that rely on microbial signatures and methods of manufacturing […]

Protein Folding Patent Invalidity: AlphaFold and Structural Biology Literature as Prior Art

How AI-predicted structures, public databases and decades of folding research reshape novelty and obviousness Introduction For fifty years the “protein folding problem”, predicting a protein’s three-dimensional shape from its amino acid sequence, was among the great open questions in biology. The Nobel Prize in Chemistry 1972 recognised Christian Anfinsen’s work showing that sequence determines structure. […]

Tissue Engineering Patent Invalidity

Using Biomaterials journal research as prior art Introduction Tissue engineering combines cells, scaffolds and biologically active signals to repair or replace tissue. It grew out of academic laboratories and much of its foundational knowledge was published in scientific journals long before it was claimed in patents. One of the leading venues for that literature is […]

Personalized Medicine Patent Invalidity: Genomic Research Publications as Prior Art

How the public literature of genomics – GWAS papers, data repositories, preprints and drug labels – can anticipate or render obvious personalized andmedicine claims 1. Introduction Personalized (or precision) medicine claims typically follow a recognisable template: determine a patient’s genotype, biomarker level or expression signature; use that result to select a drug, dose or monitoring […]